Friday, September 16, 2016

Lipitor



Generic Name: atorvastatin (Oral route)

a-tor-va-STAT-in

Commonly used brand name(s)

In the U.S.


  • Lipitor

Available Dosage Forms:


  • Tablet

Therapeutic Class: Antihyperlipidemic


Pharmacologic Class: HMG-COA Reductase Inhibitor


Uses For Lipitor


Atorvastatin is used to lower cholesterol and triglyceride (fat-like substances) levels in the blood. Using this medicine may help prevent medical problems (e.g., chest pain, heart attack, or stroke) caused by such substances clogging the blood vessels. This medicine may also be used to prevent certain types of heart problems in adults with risk factors for heart problems .


Atorvastatin belongs to the group of medicines called 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. It works by blocking an enzyme that is needed by the body to make cholesterol, thereby reducing the amount of cholesterol in the blood.


Atorvastatin is available only with your doctor's prescription.


Importance of Diet


Before prescribing medicine for your condition, your doctor will probably try to control your condition by prescribing a personal diet for you. Such a diet may be low in fats, sugars, and/or cholesterol. Many people are able to control their condition by carefully following their doctor's orders for proper diet and exercise. Medicine is prescribed only when additional help is needed and is effective only when a schedule of diet and exercise is properly followed.


Also, Lipitor is less effective if you are greatly overweight. It may be very important for you to go on a weight-reducing diet. However, check with your doctor before going on any diet.


Before Using This Medicine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


In addition to its helpful effects in treating your medical problem, this type of medicine may have some harmful effects.


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


This medicine is safe to use in boys and some girls 10 to 17 years of age for treating certain types of high cholesterol.


Geriatric


This medicine has been tested in a limited number of patients 65 years of age or older and has not been shown to cause different problems in older people than it does in younger adults. However, blood levels of atorvastatin tend to be higher in older people than they do in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Telaprevir

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Atazanavir

  • Bezafibrate

  • Ciprofibrate

  • Clarithromycin

  • Clofibrate

  • Conivaptan

  • Dalfopristin

  • Danazol

  • Daptomycin

  • Diltiazem

  • Erythromycin

  • Fenofibrate

  • Fluconazole

  • Fusidic Acid

  • Gemfibrozil

  • Itraconazole

  • Ketoconazole

  • Mibefradil

  • Nefazodone

  • Niacin

  • Posaconazole

  • Quinupristin

  • Telithromycin

  • Tipranavir

  • Troleandomycin

  • Verapamil

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Amprenavir

  • Azithromycin

  • Bexarotene

  • Black Cohosh

  • Bosentan

  • Colchicine

  • Cyclosporine

  • Darunavir

  • Digoxin

  • Efavirenz

  • Eltrombopag

  • Etravirine

  • Fosamprenavir

  • Fosphenytoin

  • Indinavir

  • Lopinavir

  • Nelfinavir

  • Oat Bran

  • Pectin

  • Phenytoin

  • Pioglitazone

  • Quinine

  • Rifampin

  • Saquinavir

  • St John's Wort

  • Voriconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.


  • Grapefruit Juice

Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Alcohol abuse (or history of) or

  • Liver disease, history—Use with caution. These conditions may increase the amount of atorvastatin in your blood .

  • Convulsions (seizures), not well-controlled, or

  • Electrolyte or metabolic enzyme deficiencies or disorders or

  • Infection, severe or

  • Low blood pressure or

  • Major surgery or trauma, recent—Patients with these conditions may be at risk of developing muscle problems (causing the release of muscle pigment into the urine) that may lead to kidney failure.

  • Kidney disease, severe—Use with caution. This medicine may make the condition worse .

  • Liver disease, active or

  • Liver enzymes, persistently high levels—This medicine should not be used in these conditions. Use of this medicine may make liver problems worse .

  • Stroke, recent or

  • Transient ischemic attack (TIA), recent—Atorvastatin may increase the risk of stroke in patients with any of these conditions .

Proper Use of Lipitor


Use this medicine only as directed by your doctor. Do not use more or less of it, and do not use it more often or for a longer time than your doctor ordered. Also, this medicine works best if there is a constant amount in the blood. To help keep this amount constant, do not miss any doses and take the medicine at the same time each day.


Remember that this medicine will not cure your condition but it does help control it. Therefore, you must continue to take it as directed if you expect to keep your cholesterol levels down.


Follow carefully the special diet your doctor gave you. This is the most important part of controlling your condition and is necessary if the medicine is to work properly.


Atorvastatin should not be taken with large amounts of grapefruit juice or other grapefruit products because these may increase the concentrations of atorvastatin in the body.


This medicine may be taken with or without food .


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For high cholesterol:
    • For oral dosage form (tablets):
      • Adults—At first, 10 or 20 milligrams (mg) once daily. Your doctor may increase your dose up to a maximum of 80 mg per day if needed.

      • Children (10 to 17 years of age)—At first, 10 milligrams (mg) once daily. Your doctor may increase your dose up to a maximum of 20 mg per day if needed.

      • Children (less than 10 years of age)—Use and dose must be determined by your doctor .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Lipitor


It is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly to lower your cholesterol and triglyceride levels and to decide if you should continue to take it.


Check with your doctor immediately if you think that you may be pregnant. HMG-CoA reductase inhibitors may cause birth defects or other problems in the baby if taken during pregnancy.


Before having any kind of surgery (including dental surgery) or emergency treatment, tell the medical doctor or dentist in charge that you are taking this medicine.


Do not take over-the-counter (OTC) niacin preparations without consulting your doctor. Niacin may increase atorvastatin's adverse effects on muscle, which can lead to serious kidney problems.


Do not use excessive amounts of alcohol while taking atorvastatin because it can worsen the adverse effects of this medicine on the liver.


Check with your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness, especially if it is accompanied by unusual tiredness or fever, because the medicine's adverse effects on muscle can lead to serious kidney problems.


Lipitor Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Less common or rare
  • Cough

  • difficulty swallowing

  • dizziness

  • fast heartbeat

  • hives

  • itching

  • muscle cramps, pain, stiffness, swelling, or weakness, especially if accompanied by unusual tiredness or fever

  • persistent elevation of liver function tests

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • shortness of breath

  • skin rash

  • tightness in chest

  • unusual tiredness or weakness

  • wheezing

Frequency not determined
  • Blistering, peeling, loosening of skin

  • chills

  • dark-colored urine

  • diarrhea

  • fever

  • itching

  • joint pain

  • large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • red skin lesions, often with a purple center sore

  • red, irritated eyes

  • redness, tenderness, itching, burning, or peeling of skin

  • sore throat

  • sores, ulcers, or white spots in mouth or on lips

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Headache

  • hoarseness

  • lower back or side pain

  • pain or tenderness around eyes and cheekbones

  • painful or difficult urination

  • stuffy or runny nose

Less common
  • Abdominal pain

  • accidental injury

  • back pain

  • belching or excessive gas

  • constipation

  • general feeling of discomfort or illness

  • heartburn, indigestion, or stomach discomfort

  • lack or loss of strength

  • loss of appetite

  • nausea

  • shivering

  • sweating

  • trouble sleeping

  • vomiting

Frequency not determined
  • Appetite increased

  • black, tarry stools

  • blindness

  • bloody nose

  • bloody or cloudy urine

  • bluish color changes in skin

  • blurred vision

  • bruising, large, flat, blue patches on the skin

  • chapped, red, or swollen lips

  • continuing ringing or buzzing or other unexplained noise in ears

  • depersonalization

  • difficult, burning, or painful urination

  • difficulty seeing at night

  • dysphoria

  • euphoria

  • excessive muscle tone or tension

  • frequent urge to urinate or defecate

  • fruit-like breath odor

  • groin or scrotum pain

  • inability to have or keep an erection

  • increased body movements

  • increased sensitivity of eyes to light

  • increased sensitivity to touch or pain

  • increased thirst

  • increased urination

  • loss of bladder control

  • loss of sexual ability, drive, or desire

  • lumps in breasts

  • mental depression

  • nervousness

  • nightmares

  • normal menstrual bleeding occurring earlier or lasting longer

  • pale skin

  • paranoia

  • pinpoint red spots on skin

  • slurred speech

  • swollen or tender lymph glands in neck, armpit, or groin

  • transient, mild, pleasant aromatic odor

  • unable to move or feel face

  • unusual bleeding or bruising

  • weight loss

  • yellow skin or eyes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Lipitor side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Lipitor resources


  • Lipitor Side Effects (in more detail)
  • Lipitor Dosage
  • Lipitor Use in Pregnancy & Breastfeeding
  • Drug Images
  • Lipitor Drug Interactions
  • Lipitor Support Group
  • 26 Reviews for Lipitor - Add your own review/rating


  • Lipitor Prescribing Information (FDA)

  • Lipitor Consumer Overview

  • Lipitor Monograph (AHFS DI)

  • Lipitor MedFacts Consumer Leaflet (Wolters Kluwer)

  • Atorvastatin Prescribing Information (FDA)



Compare Lipitor with other medications


  • High Cholesterol
  • High Cholesterol, Familial Heterozygous
  • High Cholesterol, Familial Homozygous
  • Hyperlipoproteinemia
  • Hyperlipoproteinemia Type IIa, Elevated LDL
  • Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
  • Hyperlipoproteinemia Type III, Elevated beta-VLDL IDL
  • Hyperlipoproteinemia Type IV, Elevated VLDL
  • Prevention of Cardiovascular Disease

Lanoxin Elixir



Pronunciation: di-JOX-in
Generic Name: Digoxin
Brand Name: Lanoxin


Lanoxin Elixir is used for:

Treating heart failure or slowing the heart rate in patients with chronic atrial fibrillation, a type of abnormal heart rhythm. It may also be used for other conditions as determined by your doctor.


Lanoxin Elixir is a digitalis glycoside. It works by increasing the force of contraction of the heart and slowing heart rate.


Do NOT use Lanoxin Elixir if:


  • you are allergic to any ingredient in Lanoxin Elixir

  • you are taking sucralfate

  • you have certain types of heart rhythm problems, such as ventricular fibrillation

Contact your doctor or health care provider right away if any of these apply to you.



Before using Lanoxin Elixir:


Some medical conditions may interact with Lanoxin Elixir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have severe heart failure or other heart problems (eg, inflammation, heart block, cor pulmonale, cardiomyopathy, amyloid heart disease ), extra heart beats (premature ventricular contractions [PVCs]), other types of abnormal heart rhythm, heart problems due to low thiamine (eg, beriberi heart disease), Wolff-Parkinson-White syndrome, heart blood vessel problems, or fainting due to a heart problem

  • if you have severe kidney, liver, or lung problems, or thyroid problems

  • if you have low blood levels of calcium, magnesium, or potassium, or high blood levels of potassium or calcium

  • if you have had a recent heart attack

Some MEDICINES MAY INTERACT with Lanoxin Elixir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Alprazolam, amiodarone, amphotericin B, anticholinergics (eg, propantheline), beta-blockers (eg, propranolol, carvedilol), bupivacaine, calcium, cyclosporine, diltiazem, diphenoxylate, diuretics (eg, furosemide, hydrochlorothiazide), indomethacin, itraconazole, macrolides (eg, erythromycin), propafenone, quinidine, quinine, spironolactone, stimulants (eg, amphetamine), succinylcholine, sympathomimetics (eg, albuterol, pseudoephedrine), tetracyclines (eg, doxycycline), thioamines (eg, methimazole), or verapamil because they may increase the risk of Lanoxin Elixir's side effects, especially on the heart

  • Acarbose, certain anticancer medicines, cholestyramine, colestipol, kaolin-pectin, metoclopramide, penicillamine, rifampin, sulfasalazine, or thyroid hormones (eg, levothyroxine) because they may decrease Lanoxin Elixir's effectiveness

  • Oral aminoglycosides (eg, neomycin) because the actions and side effects of Lanoxin Elixir may be increased or decreased

  • Spironolactone because it may interfere with certain lab tests for digoxin blood levels and give incorrect readings

This may not be a complete list of all interactions that may occur. Ask your health care provider if Lanoxin Elixir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Lanoxin Elixir:


Use Lanoxin Elixir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Lanoxin Elixir by mouth. Do not take it within 1 hour of food high in fiber.

  • Do not take antacids containing aluminum or magnesium, cholestyramine, or colestipol within 2 to 4 hours of taking Lanoxin Elixir.

  • Use the dropper that comes with Lanoxin Elixir to measure your dose. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Lanoxin Elixir, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Lanoxin Elixir.



Important safety information:


  • Lanoxin Elixir may cause dizziness or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Lanoxin Elixir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Tell your doctor or dentist that you take Lanoxin Elixir before you receive any medical or dental care, emergency care, or surgery.

  • Lanoxin Elixir may interfere with certain lab tests, including an electrocardiogram (ECG). Be sure your doctor and lab personnel know you are using Lanoxin Elixir.

  • Lab tests, including ECG, electrolytes, kidney function, and blood digoxin levels, may be performed while you use Lanoxin Elixir. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Lanoxin Elixir with caution in the ELDERLY; they may be more sensitive to its effects.

  • Use Lanoxin Elixir with extreme caution in NEWBORN INFANTS, especially those who are premature or immature; they may be more sensitive to its effects.

  • Poisoning may occur in children who accidently swallow Lanoxin Elixir or receive too much medicine. In case of an overdose, call a doctor or poison control center right away.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Lanoxin Elixir while you are pregnant. Lanoxin Elixir is found in breast milk. If you are or will be breast-feeding while you are taking Lanoxin Elixir, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Lanoxin Elixir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; nausea.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision, yellow vision, or other vision changes; confusion; fast, slow, or irregular heartbeat; hallucinations; mood or mental changes (eg, depression); severe or persistent nausea, vomiting, or stomach pain; unusual bruising or bleeding; unusual tiredness or weakness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Lanoxin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include very fast, very slow, or irregular heartbeat.


Proper storage of Lanoxin Elixir:

Store Lanoxin Elixir at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Lanoxin Elixir out of the reach of children and away from pets.


General information:


  • If you have any questions about Lanoxin Elixir, please talk with your doctor, pharmacist, or other health care provider.

  • Lanoxin Elixir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Lanoxin Elixir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Lanoxin resources


  • Lanoxin Side Effects (in more detail)
  • Lanoxin Use in Pregnancy & Breastfeeding
  • Drug Images
  • Lanoxin Drug Interactions
  • Lanoxin Support Group
  • 0 Reviews for Lanoxin - Add your own review/rating


Compare Lanoxin with other medications


  • Atrial Fibrillation
  • Heart Failure

Lioresal Double Strength


Generic Name: baclofen (Oral route)

BAK-loe-fen

Commonly used brand name(s)

In Canada


  • Lioresal

  • Lioresal Double Strength

Available Dosage Forms:


  • Tablet

Therapeutic Class: Skeletal Muscle Relaxant, Centrally Acting


Chemical Class: Gamma Aminobutyric Acid (class)


Uses For Lioresal Double Strength


Baclofen is used to help relax certain muscles in your body. It relieves the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis or certain injuries to the spine. Baclofen does not cure these problems, but it may allow other treatment, such as physical therapy, to be more helpful in improving your condition.


Baclofen acts on the central nervous system (CNS) to produce its muscle relaxant effects. Its actions on the CNS may also cause some of the medicine's side effects. Baclofen may also be used to relieve other conditions as determined by your doctor.


This medicine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, baclofen is used in certain patients with trigeminal neuralgia (severe burning or stabbing pain along the nerves in the face); also called ''tic douloureux.''


Before Using Lioresal Double Strength


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of baclofen in children with use in other age groups.


Geriatric


Side effects such as hallucinations, confusion or mental depression, other mood or mental changes, and severe drowsiness may be especially likely to occur in elderly patients, who are usually more sensitive than younger adults to the effects of baclofen.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Type 2 diabetes mellitus—Baclofen may raise blood sugar levels

  • Epilepsy or

  • Kidney disease or

  • Mental or emotional problems or

  • Stroke or other brain disease—The chance of side effects may be increased

Proper Use of baclofen

This section provides information on the proper use of a number of products that contain baclofen. It may not be specific to Lioresal Double Strength. Please read with care.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablets):
    • For muscle relaxation:
      • Adults and teenagers—At first, the dose is 5 milligrams (mg) three times a day. Then, each dose may be increased by 5 mg every three days until the desired response is reached. No more than 80 mg should be taken within a twenty-four-hour period.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Lioresal Double Strength


Do not suddenly stop taking this medicine. Unwanted effects may occur if the medicine is stopped suddenly. Check with your doctor for the best way to reduce gradually the amount you are taking before stopping completely.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that slow down the nervous system, possibly causing drowsiness). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates; medicine for seizures; other muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are using baclofen.


This medicine may cause drowsiness, dizziness, vision problems, or clumsiness or unsteadiness in some people. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not alert, well-coordinated, and able to see well.


For diabetic patients:


  • This medicine may cause your blood sugar levels to rise. If you notice a change in the results of your blood or urine sugar test or if you have any questions about this, check with your doctor.

Lioresal Double Strength Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Less common or rare
  • Bloody or dark urine

  • chest pain

  • fainting

  • hallucinations (seeing or hearing things that are not there)

  • mental depression or other mood changes

  • ringing or buzzing in the ears

  • skin rash or itching

Symptoms of overdose
  • Blurred or double vision

  • convulsions (seizures)

  • muscle weakness (severe)

  • shortness of breath or unusually slow or troubled breathing

  • vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Confusion

  • dizziness or lightheadedness

  • drowsiness

  • nausea

  • unusual weakness, especially muscle weakness

Less common or rare
  • Abdominal or stomach pain or discomfort

  • clumsiness, unsteadiness, trembling, or other problems with muscle control

  • constipation

  • diarrhea

  • difficult or painful urination or decrease in amount of urine

  • false sense of well-being

  • frequent urge to urinate or uncontrolled urination

  • headache

  • loss of appetite

  • low blood pressure

  • muscle or joint pain

  • numbness or tingling in hands or feet

  • pounding heartbeat

  • sexual problems in males

  • slurred speech or other speech problems

  • stuffy nose

  • swelling of ankles

  • trouble in sleeping

  • unexplained muscle stiffness

  • unusual excitement

  • unusual tiredness

  • weight gain

After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:


  • Convulsions (seizures)

  • hallucinations (seeing or hearing things that are not there)

  • increase in muscle spasm, cramping, or tightness

  • mood or mental changes

  • unusual nervousness or restlessness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Lioresal Double Strength side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Lioresal Double Strength resources


  • Lioresal Double Strength Side Effects (in more detail)
  • Lioresal Double Strength Dosage
  • Lioresal Double Strength Use in Pregnancy & Breastfeeding
  • Drug Images
  • Lioresal Double Strength Drug Interactions
  • Lioresal Double Strength Support Group
  • 5 Reviews for Lioresal Double Strength - Add your own review/rating


Compare Lioresal Double Strength with other medications


  • Alcohol Withdrawal
  • Cerebral Spasticity
  • Cervical Dystonia
  • Dystonia
  • Hiccups
  • Huntington's Disease
  • Migraine Prevention
  • Muscle Spasm
  • Muscle Twitching
  • Neuralgia
  • Periodic Limb Movement Disorder
  • Spasticity
  • Trigeminal Neuralgia

Lioresal



baclofen

Dosage Form: Tablets

C98-22 (Rev. 4/98)

667794


   Lioresal®


   baclofen USP




   Tablets


   10 mg


   20 mg




   Muscle Relaxant, Antispastic




   Rx only


   Prescribing Information



Lioresal Description


Lioresal, baclofen USP, is a muscle relaxant and antispastic, available as 10-mg and 20-mg tablets for oral administration. Its chemical name is 4-amino-3-(4-chlorophenyl)- butanoic acid, and its structural formula is








Baclofen USP is a white to off-white, odorless or practically odorless crystalline powder, with a molecular weight of 213.66. It is slightly soluble in water, very slightly soluble in methanol, and insoluble in chloroform.




Inactive Ingredients. Cellulose compounds, magnesium stearate, povidone, and starch.



ACTIONS


The precise mechanism of action of Lioresal is not fully known. Lioresal is capable of inhibiting both monosynaptic and polysynaptic reflexes at the spinal level, possibly by hyperpolarization of afferent terminals, although actions at supraspinal sites may also occur and contribute to its clinical effect. Although Lioresal is an analog of the putative inhibitory neurotransmitter gamma-aminobutyric acid (GABA), there is no conclusive evidence that actions on GABA systems are involved in the production of its clinical effects. In studies with animals, Lioresal has been shown to have general CNS depressant properties as indicated by the production of sedation with tolerance, somnolence, ataxia, and respiratory and cardiovascular depression. Lioresal is rapidly and extensively absorbed and eliminated. Absorption may be dose-dependent, being reduced with increasing doses. Lioresal is excreted primarily by the kidney in unchanged form and there is relatively large intersubject variation in absorption and/or elimination.



INDICATIONS


Lioresal is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.




Patients should have reversible spasticity so that Lioresal treatment will aid in restoring residual function.




Lioresal may also be of some value in patients with spinal cord injuries and other spinal cord diseases.




Lioresal is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.




The efficacy of Lioresal in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.



Contraindications


Hypersensitivity to baclofen.



Warnings



a.   Abrupt Drug Withdrawal:


Hallucinations and seizures have occurred on abrupt withdrawal of Lioresal. Therefore, except for serious adverse reactions, the dose should be reduced slowly when the drug is discontinued.



b.   Impaired Renal Function:


Because Lioresal is primarily excreted unchanged through the kidneys, it should be given with caution, and it may be necessary to reduce the dosage.



c.   Stroke:


Lioresal has not significantly benefited patients with stroke. These patients have also shown poor tolerability to the drug.



d.   Pregnancy:


Lioresal has been shown to increase the incidence of omphaloceles (ventral hernias) in fetuses of rats given approximately 13 times the maximum dose recommended for human use, at a dose which caused significant reductions in food intake and weight gain in dams. This abnormality was not seen in mice or rabbits. There was also an increased incidence of incomplete sternebral ossification in fetuses of rats given approximately 13 times the maximum recommended human dose, and an increased incidence of unossified phalangeal nuclei of forelimbs and hindlimbs in fetuses of rabbits given approximately 7 times the maximum recommended human dose. In mice, no teratogenic effects were observed, although reductions in mean fetal weight with consequent delays in skeletal ossification were present when dams were given 17 or 34 times the human daily dose. There are no studies in pregnant women. Lioresal should be used during pregnancy only if the benefit clearly justifies the potential risk to the fetus.



Precautions


Because of the possibility of sedation, patients should be cautioned regarding the operation of automobiles or other dangerous machinery, and activities made hazardous by decreased alertness. Patients should also be cautioned that the central nervous system effects of Lioresal may be additive to those of alcohol and other CNS depressants.




Lioresal should be used with caution where spasticity is utilized to sustain upright posture and balance in locomotion or whenever spasticity is utilized to obtain increased function.




In patients with epilepsy, the clinical state and electroencephalogram should be monitored at regular intervals, since deterioration in seizure control and EEG have been reported occasionally in patients taking Lioresal.




It is not known whether this drug is excreted in human milk. As a general rule, nursing should not be undertaken while a patient is on a drug since many drugs are excreted in human milk.




A dose-related increase in incidence of ovarian cysts and a less marked increase in enlarged and/or hemorrhagic adrenal glands was observed in female rats treated chronically with Lioresal.




Ovarian cysts have been found by palpation in about 4% of the multiple sclerosis patients that were treated with Lioresal for up to one year. In most cases these cysts disappeared spontaneously while patients continued to receive the drug. Ovarian cysts are estimated to occur spontaneously in approximately 1% to 5% of the normal female population.



Pediatric Use


Safety and effectiveness in pediatric patients below the age of 12 years have not been established.



Adverse Reactions


The most common is transient drowsiness (10%-63%). In one controlled study of 175 patients, transient drowsiness was observed in 63% of those receiving Lioresal compared to 36% of those in the placebo group. Other common adverse reactions are dizziness (5%-15%), weakness (5%-15%) and fatigue (2%-4%). Others reported:



Neuropsychiatric:


Confusion (1%-11%), headache (4%-8%), insomnia (2%-7%); and, rarely, euphoria, excitement, depression, hallucinations, paresthesia, muscle pain, tinnitus, slurred speech, coordination disorder, tremor, rigidity, dystonia, ataxia, blurred vision, nystagmus, strabismus, miosis, mydriasis, diplopia, dysarthria, epileptic seizure.



Cardiovascular:


Hypotension (0%-9%). Rare instances of dyspnea, palpitation, chest pain, syncope.



Gastrointestinal:


Nausea (4%-12%), constipation (2%-6%); and, rarely, dry mouth, anorexia, taste disorder, abdominal pain, vomiting, diarrhea, and positive test for occult blood in stool.



Genitourinary:


Urinary frequency (2%-6%); and, rarely, enuresis, urinary retention, dysuria, impotence, inability to ejaculate, nocturia, hematuria.



Other:


Instances of rash, pruritus, ankle edema, excessive perspiration, weight gain, nasal congestion. Some of the CNS and genitourinary symptoms may be related to the underlying disease rather than to drug therapy.




The following laboratory tests have been found to be abnormal in a few patients receiving Lioresal: increased SGOT, elevated alkaline phosphatase, and elevation of blood sugar.



Overdosage



Signs and Symptoms:


Vomiting, muscular hypotonia, drowsiness, accommodation disorders, coma, respiratory depression, and seizures.



Treatment:


In the alert patient, empty the stomach promptly by induced emesis followed by lavage. In the obtunded patient, secure the airway with a cuffed endotracheal tube before beginning lavage (do not induce emesis). Maintain adequate respiratory exchange, do not use respiratory stimulants.



Lioresal Dosage and Administration


The determination of optimal dosage requires individual titration. Start therapy at a low dosage and increase gradually until optimum effect is achieved (usually between 40-80 mg daily).




The following dosage titration schedule is suggested:




5 mg t.i.d. for 3 days


10 mg t.i.d. for 3 days


15 mg t.i.d. for 3 days


20 mg t.i.d. for 3 days




Thereafter additional increases may be necessary but the total daily dose should not exceed a maximum of 80 mg daily (20 mg q.i.d.).




The lowest dose compatible with an optimal response is recommended. If benefits are not evident after a reasonable trial period, patients should be slowly withdrawn from the drug (see WARNINGS Abrupt Drug Withdrawal).



How is Lioresal Supplied


Tablets 10 mg – oval, white, scored (imprinted Lioresal on one side and 10 twice on the scored side)




   Bottles of 100………………………………………………….NDC 0028-0023-01




   Unit Dose (blister pack)


   Box of 100 (strips of 10)………………………………………NDC 0028-0023-61




Tablets 20 mg – capsule - shaped, white, scored (imprinted Lioresal on one side and 20 twice on the scored side)




   Bottles of 100………………………………………………….NDC 0028-0033-01




   Unit Dose (blister pack)


   Box of 100 (strips of 10)………………………………………NDC 0028-0033-61




Do not store above 30ºC (86ºF). Dispense in tight container (USP).




667794                           C98 - 22 (Rev. 4/98)




Novartis Pharmaceuticals Corporation


East Hanover, New Jersey 07936




©1998 Novartis










Lioresal 
baclofen  tablet










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0028-0023
Route of AdministrationORALDEA Schedule    




















INGREDIENTS
Name (Active Moiety)TypeStrength
baclofen (baclofen)Active10 MILLIGRAM  In 1 TABLET
Cellulose compoundsInactive 
magnesium stearateInactive 
povidoneInactive 
starchInactive 






















Product Characteristics
ColorWHITE (white)Score2 pieces
ShapeOVAL (Oval)Size11mm
FlavorImprint CodeLioresal;10;10
Contains      
CoatingfalseSymbolfalse














Packaging
#NDCPackage DescriptionMultilevel Packaging
1100 TABLET In 1 BLISTER PACKNone
20028-0023-01100 TABLET In 1 BOTTLENone






Lioresal 
baclofen  tablet










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0028-0033
Route of AdministrationORALDEA Schedule    




















INGREDIENTS
Name (Active Moiety)TypeStrength
baclofen (baclofen)Active20 MILLIGRAM  In 1 TABLET
Cellulose compoundsInactive 
magnesium stearateInactive 
povidoneInactive 
starchInactive 






















Product Characteristics
ColorWHITE (white)Score2 pieces
ShapeOVAL (Capsule shaped)Size16mm
FlavorImprint CodeLioresal;20;20
Contains      
CoatingfalseSymbolfalse














Packaging
#NDCPackage DescriptionMultilevel Packaging
1100 TABLET In 1 BLISTER PACKNone
20028-0033-01100 TABLET In 1 BOTTLENone

Revised: 04/2006Novartis Pharmaceuticals Corporation

More Lioresal resources


  • Lioresal Side Effects (in more detail)
  • Lioresal Dosage
  • Lioresal Use in Pregnancy & Breastfeeding
  • Drug Images
  • Lioresal Drug Interactions
  • Lioresal Support Group
  • 5 Reviews for Lioresal - Add your own review/rating


  • Lioresal Advanced Consumer (Micromedex) - Includes Dosage Information

  • Lioresal MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lioresal Monograph (AHFS DI)

  • Baclofen Professional Patient Advice (Wolters Kluwer)

  • Gablofen Advanced Consumer (Micromedex) - Includes Dosage Information

  • Gablofen Consumer Overview



Compare Lioresal with other medications


  • Alcohol Withdrawal
  • Cerebral Spasticity
  • Cervical Dystonia
  • Dystonia
  • Hiccups
  • Huntington's Disease
  • Migraine Prevention
  • Muscle Spasm
  • Muscle Twitching
  • Neuralgia
  • Periodic Limb Movement Disorder
  • Spasticity
  • Trigeminal Neuralgia

Liotrix


Class: Thyroid Agents
ATC Class: H03AA02
VA Class: HS851
CAS Number: 8065-29-0
Brands: Thyrolar

Introduction

Synthetic thyroid agent; combination preparation containing tetraiodothyronine (levothyroxine, T4) sodium and triiodothyronine (liothyronine, T3) sodium.a b c d j


Uses for Liotrix


Hypothyroidism


Replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.a b Specific indications include primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism.a b


Not considered drug of choice for replacement therapy because offers no therapeutic advantage over levothyroxine sodium and may result in excessive serum T3 concentrations.a Levothyroxine is considered drug of choice for replacement therapy.c


For treatment of congenital hypothyroidism (cretinism), levothyroxine is considered drug of choice.a


Pituitary TSH Suppression


Treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis), multinodular goiter, and in the management of thyroid cancer.a b


Diagnosis of Thyroid Disorders


Used diagnostically in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.a b Use with caution in patients in whom there is a strong suspicion of thyroid gland autonomy because exogenous hormone effects will be additive to endogenous source.b


Thyrotoxicosis


Has been used in combination with antithyroid agents for the treatment of thyrotoxicosis to prevent goitrogenesis and hypothyroidism.a


Liotrix Dosage and Administration


General



  • Initially, monitor response to therapy about every 6–8 weeks.e k Once normalization of thyroid function and serum TSH concentrations has been achieved, patients may be evaluated less frequently (i.e., every 6–12 months).e k However, if dosage is changed, measure serum TSH concentrations after 8–12 weeks.k




  • Natural and synthetic thyroid agent preparations are not necessarily directly comparable; however, the following equivalencies have been suggested based on clinical response:j
















Equivalencies of Thyroid Preparations Based on Clinical Responsej

Thyroid Agent



Approximate Equivalent Dosage



Levothyroxine sodium



100 mcg or less



Liothyronine sodium



25 mcg



Liotrix (levothyroxine sodium/liothyronine sodium)



50 mcg/12.5 mcg (Thyrolar)



Thyroglobulin



65 mg



Thyroid



60–65 mg (1 grain)


Administration


Oral Administration


Administer orally, usually as a single daily dose before breakfast.a b


Dosage


Available as fixed-combination preparation containing levothyroxine sodium and liothyronine sodium; dosage expressed in terms of the salts of both drugs.a b


Current USP standards define liotrix as containing levothyroxine sodium and liothyronine sodium in a ratio of 4:1 by weight.a Thus, Thyrolar-1 contains 50 mcg of levothyroxine sodium and 12.5 mcg of liothyronine sodium, which is approximately equivalent to 60 mg of thyroid.a (See General under Dosage and Administration.)


Adjust dosage carefully according to clinical and laboratory response to treatment.a j Avoid undertreatment or overtreatment.j (See Therapy Monitoring under Cautions.)


Initiate at a lower dosage level in geriatric patients, in patients with functional or ECG evidence of cardiovascular disease, and in patients with severe, long-standing hypothyroidism or other endocrinopathies.a j


Pediatric Patients


Hypothyroidism

Oral

Initiate therapy at full replacement dosages as soon as possible after diagnosis of congenital hypothyroidism to prevent deleterious effects on intellectual and physical growth and development.b h The following dosages have been recommended:a















Dosage for Management of Hypothyroidism in Pediatric Patientsab

Age



Daily T3/T4 Dosage



0–6 months



3.1/12.5–6.25/25 mcg



6–12 months



6.25/25–9.35/37.5 mcg



1–5 years



9.35/37.5–12.5/50 mcg



6–12 years



12.5/50–18.75/75 mcg



>12 years



>18.75/75 mcg


When transient hypothyroidism is suspected, therapy may be temporarily discontinued when the child is >3 years of age to reassess the condition.b j m (See Pediatric Use under Cautions.)


Adults


Hypothyroidism

Oral

Usual initial dosage is one tablet of Thyrolar-1/2 daily.a b Increase by one tablet of Thyrolar-1/4 at intervals of 2–3 weeks.a b


For management of long-standing myxedema, particularly when cardiovascular impairment is suspected, usual initial dosage is one tablet of Thyrolar-1/4 daily.b


Usual maintenance dosage is one tablet of Thyrolar-1 to one tablet of Thyrolar-2 daily.a b Serum TSH and T4 concentrations usually return to normal after 2–3 weeks of therapy.a b Failure to respond adequately to one Thyrolar-3 tablet daily suggests presence of malabsorption or patient noncompliance.a b


Pituitary TSH Suppression

Thyroid Cancer

Oral

Administration of dosages higher than those used for replacement therapy usually is required to suppress TSH to low or undetectable concentrations.b Medullary carcinoma of the thyroid usually unresponsive to this therapy.b


Special Populations


Patients with Cardiovascular Disease


Hypothyroidism

Initiate therapy at lower dosages than those recommended for patients without cardiovascular disease.b j k


Usual initial dosage is one Thyrolar-1/4 tablet or one Thyrolar -1/2 tablet daily.b If angina appears or if cardiovascular disease is aggravated, reduce dosage or temporarily withhold therapy and then cautiously restart therapy at a lower dosage.b j


Geriatric Patients


Hypothyroidism

Initiate therapy at lower dosages than those recommended for younger patients.b j k


Usual initial dosage is one Thyrolar-1/4 tablet or one Thyrolar -1/2 tablet daily.b If cardiovascular disease is aggravated, reduce dosage or temporarily withhold therapy and then cautiously restart therapy at a lower dosage.b j


Cautions for Liotrix


Contraindications



  • Untreated thyrotoxicosis.b j




  • AMI uncomplicated by hypothyroidism.j




  • Uncorrected adrenal insufficiency.b j




  • Known hypersensitivity to any ingredient in the formulation.b j (See Sensitivity Reactions under Cautions.)



Warnings/Precautions


Warnings


Unlabeled Uses

Should not be used for the treatment of obesity or for weight loss either alone or with other therapeutic agents.b j k r In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction.b j r Larger doses may produce serious or life-threatening toxicity, particularly when given in conjunction with sympathomimetic amines (e.g., anorectic agents).b j r


Should not be used in the treatment of male or female infertility unless this condition is associated with hypothyroidism.b j k r


Sensitivity Reactions


Hypersensitivity to thyroid hormone is not known to occur.b However, hypersensitivity reactions to inactive ingredients of thyroid hormone products have been reported and include urticaria, pruritus, rash, flushing, angioedema, abdominal pain, nausea, vomiting, diarrhea, fever, arthralgia, serum sickness, and wheezing.j


Major Toxicities


Effects on Bone Mineral Density

Increased markers of bone turnover.d


General Precautions


Therapy Monitoring

Thyroid agents have a narrow therapeutic index.j Avoid undertreatment or overtreatment, which may result in adverse effects on growth and development in pediatric patients, cardiovascular function, bone metabolism, reproductive function, cognitive function, emotional state, GI function, and glucose and lipid metabolism.j


Periodically perform appropriate laboratory tests (e.g., serum TSH, total or free T4, total T3) and clinical evaluations to monitor adequacy of therapy.a b c j


Preexisting Cardiovascular Disease

Use with extreme caution.b j (See Patients with Cardiovascular Disease under Dosage and Administration.) Patients with CHD should be monitored closely during surgical procedures due to increased risk of arrhythmias.j


Associated Endocrine Disorders

Hypopituitarism, adrenal insufficiency, and other endocrine disorders such as diabetes mellitus and diabetes insipidus are characterized by signs and symptoms which may be diminished in severity or obscured by hypothyroidism.j Thyroid agents may aggravate the intensity of previously obscured symptoms in patients with endocrine disorders, and appropriate adjustment of therapy for these concomitant disorders may be required.b j


In patients with secondary or tertiary hypothyroidism, consider possibility of additional hypothalamic/pituitary hormone deficiencies and treat if diagnosed.q


Chronic autoimmune thyroiditis may occur in association with other autoimmune disorders (e.g., adrenal insufficiency, pernicious anemia, type 1 diabetes mellitus.)e f


Patients with concomitant adrenal insufficiency should be treated with replacement corticosteroids prior to initiation of thyroid agents.j Failure to do so may precipitate an acute adrenal crisis due to increased metabolic clearance of corticosteroids when the thyroid agent is initiated.j


Patients with diabetes mellitus may require increased dosages of antidiabetic agents when treated with thyroid agents.b j


Specific Populations


Pregnancy

Category A.b


During pregnancy, serum free T4 levels may decrease and serum TSH levels increase to values outside the normal range.d q Elevations in serum TSH may occur at 4 weeks’ gestation;q monitor TSH levels during each trimester (or every 6 weeks) and adjust liotrix dosage accordingly.d e k Reduce dosage to pre-pregnancy level immediately after delivery, since postpartum TSH concentrations are similar to preconception levels; measure serum TSH concentrations 6–8 weeks postpartum.q


Lactation

Although thyroid hormones are distributed minimally into human milk, exercise caution when administering to a nursing woman.b However, adequate replacement dosages generally are needed to maintain normal lactation.o q


Pediatric Use

The goal of treatment in pediatric patients with hypothyroidism is to achieve and maintain normal intellectual and physical growth and development.b j Initiate therapy immediately upon diagnosis.b j Maintain therapy for life, unless transient hypothyroidism is suspected.b j


Neonates with suspected hypothyroidism should receive thyroid agent therapy pending results of confirmative tests.j If a positive diagnosis cannot be made on the basis of laboratory findings but there is a strong clinical suspicion of congenital hypothyroidism, initiate replacement therapy to achieve euthyroidism until the child is 1–2 years of age.j During the first 2 weeks of therapy, closely monitor infants for cardiac overload, arrhythmias, and aspiration resulting from avid suckling.j Evaluate infant’s clinical response to therapy about 6 weeks after initiation of thyroid agent therapy and at least at 6 and 12 months of age and yearly thereafter.j


When transient hypothyroidism is suspected, temporarily discontinue therapy for 2–8 weeks to reassess the condition when the child is >3 years of age.b j m If the diagnosis of permanent hypothyroidism is confirmed, reinstitute full replacement therapy.j However, if serum concentrations of free T4 and TSH are normal, discontinue thyroid agent therapy and monitor carefully;b j repeat thyroid function tests if manifestations of hypothyroidism develop.j


In pediatric patients with transient severe hypothyroidism, reduce replacement dose by half for 30 days to reassess condition.m If, after 30 days, serum TSH >20 mU/L, consider the hypothyroidism permanent and reinstitute full replacement therapy.m However, if serum TSH has not increased, temporarily discontinue thyroid agent therapy for another 30 days, then repeat serum free T4 and TSH measurements.m Reinstitute or discontinue replacement therapy based on laboratory findings.m


Monitor patients closely to avoid undertreatment or overtreatment.j Undertreatment may result in poor school performance (due to impaired concentration and slowed mentation) and reduced adult height.j Overtreatment may result in craniosynostosis in infants and accelerate aging of bones, resulting in premature epiphyseal closure and compromised adult stature.j m


Treated children may manifest a period of catch-up growth, which may be adequate in some cases to achieve normal adult height.j In children with severe or long-standing hypothyroidism, catch-up growth may not be adequate to achieve normal adult height.j


Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving thyroid agents.j


Geriatric Use

Because of the increased risk of cardiovascular disease among geriatric patients, liotrix therapy should not be initiated at the full replacement dose.b j k (See Geriatric Patients under Dosage and Administration.)


Common Adverse Effects


Adverse reactions result from overdosage and resemble manifestations of hyperthyroidism,a b j including fatigue,b j weight loss,j increased appetite,j heat intolerance,j fever,j excessive sweating,b j headache,b j hyperactivity,j nervousness,j anxiety,b j irritability,j emotional lability,j insomnia,b j tremor,b j muscle weakness,j palpitations,b j tachycardia,j arrhythmias,b j increased heart rate and BP,b j heart failure,j angina,j AMI,j cardiac arrest,j diarrhea,j vomiting,j abdominal cramps,j elevations in liver function test results,j hair loss,b j flushing,j decreased bone mineral density,j menstrual irregularities,j and impaired fertility.j


Interactions for Liotrix


Drugs Affecting Hepatic Microsomal Enzymes


Potential increased metabolism of thyroid agent with drugs that induce hepatic microsomal enzymes resulting in increased thyroid agent dosage requirements.j


Drugs That May Decrease T4 5’-Deiodinase Activity


Inhibitors of T4 5’ mono-deiodinase decrease peripheral conversion of T4 to T3, resulting in decreased T3 concentrations.j p However, serum T4 concentrations usually remain within normal range but may occasionally be slightly increased.j q


Specific Drugs and Foods




















































































Drug



Interaction



Comments



Amiodarone



Decreased metabolism of T4 to T3d j



Anticoagulants, oral (e.g., coumarins)



Potentiation of anticoagulant activityb j



Carefully monitor PT and adjust anticoagulant dosage accordingly when thyroid agent therapy is initiatedb j



Antidepressants (tricyclics, tetracyclics, SSRIs)



Increased risk of cardiac arrhythmias and CNS stimulation when levothyroxine is used with tricyclics or tetracyclicsj


Faster onset of action of tricyclics following concomitant use with levothyroxinej


Sertraline may increase levothyroxine requirementsj



Antidiabetic agents (biguanides, meglitinides, sulfonylureas, thiazolidinediones, insulin)



Thyroid agent may cause increased antidiabetic agent or insulin requirementsb d j



Carefully monitor diabetic control, especially when thyroid therapy is initiated, changed, or discontinuedb d j



β-Adrenergic blocking agents (e.g., propranolol hydrochloride dosages >160 mg daily)



Decreased metabolism of T4 to T3j


Impaired antihypertensive effects when hypothyroid patient is converted to euthyroid statej



Bile acid sequestrants (e.g., cholestyramine, colestipol)



Impaired thyroid agent absorptionb d j



Administer liotrix ≥4 hours apart from these agentsb j



Carbamazepine



Potential increased metabolism of thyroid agentd j


Reduced levothyroxine serum protein bindingj



May require thyroid agent dosage increasej q



Cardiac glycosides



Decreased serum digitalis glycoside concentrations in patients with hyperthyroidism or in patients with hypothyroidism in whom a euthyroid state has been achieved; potential for reduced therapeutic effects of digitalis glycosides with thyroid agent usej



May need to increase dosage of digitalis glycoside when hypothyroidism has been correctedd q



Corticosteroids (e.g., dexamethasone at dosages ≥4 mg daily)



Decreased metabolism of T4 to T3j


Short-term administration of large doses of corticosteroids may decrease serum T3 concentrations by 30% with minimal change in serum T4 concentrationsj



Estrogen or estrogen-containing oral contraceptives



Possible decreased free T4 concentrationsb d j



Patients without a functioning thyroid gland may require liotrix dosage increaseb j



Ferrous sulfate



Delayed or impaired thyroid absorptiond j



Administer liotrix ≥4 hours apart from this agentd j



Food with large amounts of fiber (e.g., cotton seed meal, infant soybean formula, soybean flour, walnuts)



Decreased levothyroxine absorptionb q



Furosemide (at IV dosages >80 mg)



Concomitant use with levothyroxine produces transient increases in serum free T4 concentrations; continued administration results in a decrease in serum T4 and normal free T4 and TSH concentrations, and therefore, patients are clinically euthyroidj



GI drugs (e.g., antacids [aluminum hydroxide, magnesium hydroxide, calcium carbonate], simethicone, sucralfate)



Delayed or impaired thyroid agent absorptiond j



Administer liotrix ≥4 hours apart from these agentsd



Growth hormones (e.g., somatropin)



Excessive use of thyroid agents with growth hormones may accelerate epiphyseal closure; however, untreated hypothyroidism may interfere with growth response to growth hormonej



Heparin



Concomitant use with levothyroxine produces transient increases in serum free T4 concentrations; continued administration results in a decrease in serum T4 and normal free T4 and TSH concentrations, and therefore, patients are clinically euthyroidj



Hydantoins (e.g., phenytoin)



Potential increased metabolism of thyroid agentd j


Reduced levothyroxine serum protein bindingd j


Concomitant use with levothyroxine produces transient increases in serum free T4 concentrations; continued administration results in a decrease in serum T4 and normal free T4 and TSH concentrations, and therefore, patients are clinically euthyroidj



May require thyroid agent dosage increasej



Ketamine



Risk of marked hypertension and tachycardiaj



Use with cautionj



NSAIAs (e.g., fenamates, phenylbutazone)



Concomitant use with levothyroxine produces transient increases in serum free T4 concentrations; continued administration results in a decrease in serum T4 and normal free T4and TSH concentrations, and therefore, patients are clinically euthyroidj



Phenobarbital



Potential increased metabolism of thyroid agentd j



May require thyroid agent dosage increasej



Radiographic agents (iodine-containing)



Reduced uptake of 123I, 131I, and 99mTcj



Rifampin



Potential increased metabolism of thyroid agentj



May require thyroid agent dosage increasej



Salicylates (dosages >2 g daily)



Concomitant use with levothyroxine produces transient increases in serum free T4 concentrations; continued administration results in a decrease in serum T4 and normal free T4and TSH concentrations, and therefore, patients are clinically euthyroidj



Sodium polystyrene sulfonate



Delayed or impaired thyroid absorptiond j



Administer liotrix ≥4 hours apart from this agentj



Sympathomimetic agents



Potentiation of sympathomimetic effects; increased risk of coronary insufficiency in patients with CADj



Observe patient carefully when sympathomimetic agent is administeredj



Xanthine derivatives (e.g., theophylline)



Clearance of xanthine derivatives may be decreased in hypothyroid patients but returns to normal when the euthyroid state is achievedd j


Drugs Affecting Thyroid Function or Thyroid Function Tests


Various drugs or concomitant medical conditions (e.g., pregnancy, infectious hepatitis) may adversely affect thyroid function (e.g., alter endogenous thyroid hormone secretion, reduce TSH secretion) resulting in hypothyroidism or hyperthyroidism or interfere with laboratory tests used to assess thyroid function.b j Consult specialized references for information.


Some drugs may affect transport of thyroid hormones (T3, T4) by affecting serum thyroxine-binding globulin (TBG) concentrations.j q However, free T4 concentrations may remain normal and the patient may remain euthyroid.j q Monitor therapy and adjust liotrix dosage as necessary.j


Drugs Affecting Thyroxine Binding Globulin Concentrationsb j


  • Drugs That May Increase Serum TBG Concentration


  • Estrogens, oral (including estrogen-containing oral contraceptives)b j




  • Fluorouracilj




  • Methadonej




  • Mitotanej




  • Tamoxifenj



  • Drugs That May Decrease Serum TBG Concentration


  • Androgensb j




  • Asparaginasej




  • Corticosteroidsb j




  • Niacin (extended-release)j



Liotrix Pharmacokinetics


Absorption


Bioavailability


Levothyroxine (T4): Variably absorbed from the GI tract (range: 40–80%).b j Extent of absorption is increased in the fasting state and decreased in malabsorption states.b j


Liothyronine (T3): Almost completely absorbed from the GI tract (about 95%).b h j


Onset


Liothyronine has a more rapid onset of action than levothyroxine (24–72 hours versus 1–3 weeks).h i j


Distribution


Extent


T4 is distributed throughout most body tissues and fluids; highest concentrations found in liver and kidneys.j


Thyroid hormones do not readily cross the placenta;b j q however, some transfer does occur, as evidenced by levels in cord blood of athyrotic fetuses being approximately one-third maternal levels.q


Thyroid hormones are minimally distributed into breast milk.b j q


Plasma Protein Binding


Circulating thyroid hormones are >99% bound to serum proteins, including TBG, thyroxine-binding prealbumin (TBPA), and albumin.b j q T4 is more extensively and firmly bound to TBG and TBPA than T3.b j q Only unbound hormone is metabolically active.b q


Elimination


Metabolism


T4 and T3 are metabolized principally in the liver through sequential deiodination.b j q Approximately 80% of the daily dose of T4 is deiodinated to yield equal amounts of T3 and reverse T3 (rT3).j q T3 and rT3 are further deiodinated to diiodothyronine.j q Thyroid hormones are also metabolized via conjugation with glucuronides and sulfates and excreted directly into the bile and gut where they undergo enterohepatic recirculation.b j q


Elimination Route


Thyroid hormones are primarily eliminated by the kidneys.q A portion of the conjugated hormone reaches the colon unchanged and is eliminated in the feces.q Approximately 20% of T4 is eliminated in stool.q Urinary excretion of T4 decreases with age.q


Half-life


T4: Approximately 6–7 days.h i j


T3: Approximately 1–2 days.c h i j


These plasma half-lives are decreased in patients with hyperthyroidism and increased in those with hypothyroidism.h i j


Stability


Storage


Oral


Tablets

Tight, light-resistant containers at 2–8°C.a b


ActionsActions



  • Thyroid hormones (T4 and T3) regulate multiple metabolic processes, including augmentation of cellular respiration and thermogenesis, as well as metabolism of proteins, carbohydrates, and lipids.b j q




  • Thyroid hormones also play an essential role in normal growth and development and normal maturation of the CNS and bone.b j The protein anabolic effects of thyroid hormones are essential for normal growth and development.j q




  • The physiologic actions of thyroid hormones are produced predominantly by T3, most of which (approximately 80%) is derived from T4 by deiodination in peripheral tissues.b j




  • T3 is approximately 4 times more potent than T4.b



Advice to Patients



  • Importance of understanding the need to continue thyroid agent therapy for life, unless transient hypothyroidism is suspected.b j




  • Importance of taking thyroid agent exactly as prescribed.q Do not alter regimen or discontinue therapy unless directed by a clinician.q




  • Risk of transient hair loss.b q Importance of immediately informing a clinician if rapid or irregular heartbeat, chest pain, shortness of breath, leg cramps, headache, nervousness, irritability, sleeplessness, tremors, change in appetite, weight gain or loss, vomiting, diarrhea, excessive sweating, heat intolerance, fever, changes in menstrual periods, hives or skin rash, or any other unusual medical event occurs.b q




  • Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs and herbal supplements, as well as any concomitant illnesses (e.g., cardiovascular disease, diabetes mellitus, clotting disorders, adrenal or pituitary gland problems).b




  • In patients with diabetes mellitus, importance of monitoring blood and/or urinary glucose levels and immediately reporting any changes to a clinician.b d q In patients receiving concomitant anticoagulant therapy, importance of monitoring clotting status frequently.b




  • Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.b f Dosage may need to be increased during pregnancy.e f




  • Importance of informing physician or dentist of current thyroid hormone therapy prior to any surgery.j




  • Importance of informing patients of other important precautionary information.a b (See Cautions.)



Preparations


Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.


U.S. Pharmacopeia, an official public standards-setting authority for all prescription and over-the-counter medicines and other health care products manufactured or sold in the United States, has mandated new specifications for a component used in the manufacturing of Thyrolar. As a result, all strengths of Thyrolar are currently on long-term back order while Forest makes the modifications necessary to meet these new specifications. Forest is working diligently to complete these modifications. In the meantime, patients should speak with their physician regarding appropriate treatment for their condition, and check for future updates on the availability of Thyrolar through the Forest product availability toll-free hotline at (866) 927-3260.

































Liotrix

Routes



Dosage Forms



Strengths



Brand Names



Manufacturer



Oral



Tablets



Levothyroxine Sodium 12.5 mcg and Liothyronine Sodium 3.1 mcg



Thyrolar



Forest



Levothyroxine Sodium 25 mcg and Liothyronine Sodium 6.25 mcg



Thyrolar



Forest



Levothyroxine Sodium 50 mcg and Liothyronine Sodium 12.5 mcg



Thyrolar-1



Forest



Levothyroxine Sodium 100 mcg and Liothyronine Sodium 25 mcg



Thyrolar-2



Forest



Levothyroxine Sodium 150 mcg and Liothyronine Sodium 37.5 mcg



Thyrolar-3



Forest


Comparative Pricing


This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 04/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.


Thyrolar-1 60 (12.5-50)MG (MCG) Tablets (FOREST): 30/$29.99 or 90/$72.97


Thyrolar-1/2 30 (6.25-25)MG (MCG) Tablets (FOREST): 30/$26.99 or 90/$57.97


Thyrolar-1/4 15 (3.1-12.5)MG (MCG) Tablets (FOREST): 30/$24.99 or 90/$54.97


Thyrolar-2 120 (25-100)MG (MCG) Tablets (FOREST): 30/$32.99 or 90/$82.98


Thyrolar-3 180 (37.5-150)MG (MCG) Tablets (FOREST): 30/$39.99 or 90/$100.98



Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.


The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions July 01, 2008. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.




References



a. AHFS Drug Information 2008. McEvoy GK, ed. Liotrix. Bethesda, MD: American Society of Health-System Pharmacists; 2008:3307-8.



b. Forest Pharmaceuticals, Inc. Thyrolar (liotrix) tablets prescribing information. St. Louis, MO; 2005 Apr.



c. Dong BJ. Thyroid Disorders. In: Koda-Kimble MA, Young LY, eds. Applied therapeutics: The clinical use of drugs. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:49-1–49-19.



d. Anon. Drugs for hypothyroidism and hyperthyroidism. Treat Guidel Med Lett. 2006; 4:17–24.



e. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism, 2006 amended version. Endocr Pract; 2002:457–69.



f. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, number 37, August 2002: Thyroid disease in pregnancy. Obstet Gynecol. 2002; 100:387-96. [PubMed 12166417]



h. AHFS Drug Information 2008. McEvoy GK, ed. Liothyronine Sodium. Bethesda, MD: American Society of Health-System Pharmacists; 2008:3306-7.



i. AHFS Drug Information 2008. McEvoy GK, ed. Levothyroxine Sodium. Bethesda, MD: American Society of Health-System Pharmacists; 2008:3302-6.



j. AHFS Drug Information 2008. McEvoy GK, ed. Thyroid Agents General Statement. Bethesda, MD: American Society of Health-System Pharmacists; 2008:3298-302.



k. Singer PA, Cooper DS, Levy EG et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA; 1995; 273:808-12.



m. American Academy of Pediatrics, American Thyroid Association, and Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006; 117:2290-303. [PubMed 16740880]



o. Joshi JV, Bhandarkar SD, Chadha M et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med. 1993; 39:137-41. [PubMed 8051643]